Enanta pharmaceuticals, inc. – product pipeline


Published on

2012 | Aarkstore.com | Enanta pharmaceuticals, inc. – product pipeline

Published in: Health & Medicine
  • Be the first to comment

  • Be the first to like this

No Downloads
Total views
On SlideShare
From Embeds
Number of Embeds
Embeds 0
No embeds

No notes for slide

Enanta pharmaceuticals, inc. – product pipeline

  1. 1. You can also request for sample page of abovemention reports on sample@aarkstore.com
  2. 2. Pages : 31PDF - $ 2000 | Site Licence - $ 4000 $ | Enterprise License - $6000 |
  3. 3. SummaryGlobal Market Direct’s pharmaceuticals report, “Enanta Pharmaceuticals, Inc. -Product Pipeline Review - 2012” provides data on the Enanta Pharmaceuticals,Inc.’s research and development focus. The report includes information oncurrent developmental pipeline, complete with latest updates, and features ondiscontinued and dormant projects.This report is built using data and information sourced from Global MarketsDirect’s proprietary databases, Enanta Pharmaceuticals, Inc.’s corporatewebsite, SEC filings, investor presentations and featured press releases, bothfrom Enanta Pharmaceuticals, Inc. and industry-specific third party sources, puttogether by Global Markets Direct’s team.
  4. 4. Scope- Enanta Pharmaceuticals, Inc. - Brief Enanta Pharmaceuticals, Inc. overviewincluding business description, key information and facts, and its locations andsubsidiaries.- Review of current pipeline of Enanta Pharmaceuticals, Inc. human therapeuticdivision.- Overview of pipeline therapeutics across various therapy areas.- Coverage of current pipeline molecules in various stages of drug development,including the combination treatment modalities, across the globe.Reasons to buy- Evaluate Enanta Pharmaceuticals, Inc.’s strategic position with total access todetailed information on its product pipeline.- Assess the growth potential of Enanta Pharmaceuticals, Inc. in its therapy areas offocus.- Identify new drug targets and therapeutic classes in the Enanta Pharmaceuticals,Inc.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in thoseareas.- Exploit in-licensing opportunities by identifying windows of opportunity to fillportfolio gaps.
  5. 5. Table of Contents :List of Tables 4List of Figures 4Enanta Pharmaceuticals, Inc. Snapshot 5Enanta Pharmaceuticals, Inc. Overview 5Key Information 5Key Facts 5Enanta Pharmaceuticals, Inc. – Research and Development Overview 6Key Therapeutic Areas 6Enanta Pharmaceuticals, Inc. – Pipeline Review 8Pipeline Products by Stage of Development 8Pipeline Products – Monotherapy 9Enanta Pharmaceuticals, Inc. – Pipeline Products Glance 10Enanta Pharmaceuticals, Inc. Clinical Stage Pipeline Products 10Phase I Products/Combination Treatment Modalities 10Enanta Pharmaceuticals, Inc. – Early Stage Pipeline Products 11Pre-Clinical Products/Combination Treatment Modalities 11Discovery Products/Combination Treatment Modalities 12Enanta Pharmaceuticals, Inc. – Drug Profiles 13Bicyclolide Antibiotics 13…………….
  6. 6. Please follow link if you want More RelatedReports :Product Pipeline Review – 2012http://www.aarkstore.com/search/viewresults.asp?search=ProductPipeline Review&PubId=&pagenum=1
  7. 7. Related Reports:Eisai Co., Ltd. – Product Pipeline Review – 2012OSI Pharmaceuticals, Inc. – Product Pipeline Review – 2012Paloma Pharmaceuticals, Inc. – Product Pipeline Review – 2012Lorus Therapeutics Inc – Product Pipeline Review – 2012MediciNova, Inc. – Product Pipeline Review – 2012Molecular Insight Pharmaceuticals, Inc. – Product Pipeline Review –2012Nippon Kayaku Co., Ltd. – Product Pipeline Review – 2012Vectura Group plc – Product Pipeline Review – 2012Yakult Honsha Co., Ltd. – Product Pipeline Review – 2012Harbor Therapeutics, Inc. – Product Pipeline Review – 2012Swedish Orphan Biovitrum AB – Product Pipeline Review – 2012TaiGen Biotechnology Co., Ltd. – Product Pipeline Review – 2012Tarix Pharmaceuticals LTD. – Product Pipeline Review – 2012Telormedix SA – Product Pipeline Review – 2012Therapure Biopharma Inc. – Product Pipeline Review – 2012Tobira Therapeutics, Inc. – Product Pipeline Review – 2012ransPharma Medical Ltd. – Product Pipeline Review – 2012Valens Therapeutics, Inc. – Product Pipeline Review – 2012
  8. 8. For More details about above & otherReports plz contact :LavanyaAarkstore.comContact: Marketing team Mob.No.918149852585Email: enquiry@aarkstore.com ,discount@aarkstore.comURL: http://www.aarkstore.comhttp://in.linkedin.com/in/aarkstorehttp://www.facebook.com/aarkstore